The 9th edition of India Pharma 2026 commenced at Federation House, New Delhi, on April 13–14, 2026, highlighting India’s growing ambition to emerge as a global leader in innovation-driven pharmaceuticals and life sciences.
Organized by the Department of Pharmaceuticals, under the Ministry of Chemicals & Fertilizers, in association with FICCI and the Indian Pharmaceutical Alliance (IPA), the flagship event is themed “Discover in India: Leapfrogging Life-Sciences Innovation.”
The conference was inaugurated by Union Minister of Chemicals and Fertilizers, Jagat Prakash Nadda, along with Minister of State for Chemicals and Fertilizers, Anupriya Patel.
Driving India’s Transition to Value-Based Pharma Leadership
India Pharma 2026 reflects the country’s strategic shift from being primarily a volume-based pharmaceutical manufacturing hub to becoming a global powerhouse focused on value creation, research, and innovation.
The Government of India continues to strengthen policy support for the sector by promoting:
- Research & Development (R&D)
- Innovation-led growth
- Sustainable global supply chains
- Self-reliance in pharma and medtech manufacturing
- Global competitiveness in advanced therapeutics
Global Stakeholders Gather for Strategic Discussions
The two-day platform brings together policymakers, global pharmaceutical executives, regulators, researchers, and investors to discuss the future of healthcare and life sciences. Key focus areas include:
- Drug discovery and advanced therapeutics
- Complex generics and biosimilars
- AI-driven pharmaceutical innovation
- CRDMO (Contract Research, Development & Manufacturing Organization) opportunities
- Pharma financing and investment ecosystems
Leading Industry Participation
The event features participation from major pharmaceutical companies such as:
- Sun Pharma
- Zydus Lifesciences
- Cipla
- Abbott India
- Eli Lilly
Their presence underlines India’s increasing importance in the global pharmaceutical value chain.
Supporting Atmanirbhar Bharat and Viksit Bharat 2047
India Pharma 2026 also reinforces the nation’s commitment to Atmanirbhar Bharat in pharmaceuticals and medical technology. Through stronger industry-academia partnerships, innovation funding, and progressive policy dialogues, the event aims to contribute toward the broader vision of Viksit Bharat 2047.
As one of the country’s premier pharma platforms, India Pharma 2026 is expected to accelerate India’s journey toward becoming a trusted global center for life-sciences innovation and healthcare solutions.
